| Pharmaceutical active ingredients: |
| Medroxyprogesterone Acetate |
| Available forms, composition and doses of Farlutal: |
| Injectable; Injection; Medroxyprogesterone Acetate 200 mg / mlSuspension; Oral; Medroxyprogesterone Acetate 500 mg / 5 mlTablets; Oral; Medroxyprogesterone Acetate 10 mgTablets; Oral; Medroxyprogesterone Acetate 100 mgTablets; Oral; Medroxyprogesterone Acetate 2.5 mgTablets; Oral; Medroxyprogesterone Acetate 200 mgTablets; Oral; Medroxyprogesterone Acetate 250 mgTablets; Oral; Medroxyprogesterone Acetate 5 mgTablets; Oral; Medroxyprogesterone Acetate 500 mg |
| Farlutal medical category: |
| Human:Depot contraceptivesOestrogens and progesterones and related synthetic drugsProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AC06 - MedroxyprogesteroneG03DA02 - MedroxyprogesteroneL02AB02 - Medroxyprogesterone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerInstitute of Pharmaceutical Research and TechnologyKenfarma |